Blog

  • EESystem Triumphs Again: Courts Deem Jason Shurka’s Claims “Baseless” and “Futile”

    EESystem Triumphs Again: Courts Deem Jason Shurka’s Claims “Baseless” and “Futile”

    Judges Continue to Side with Energy Enhancement System as Jason Shurka’s Legal Maneuvers Collapse

    LAS VEGAS, NV / ACCESS Newswire / October 31, 2025 /Energy Enhancement System, LLC (“EES”) has achieved another decisive victory in its ongoing effort to defend truth, innovation, and integrity against baseless attacks from Jason Shurka and The Light System, Inc. (“TLS”).

    The United States District Court for the Eastern District of New York has formally granted EES permission to move forward with its full motion to dismiss – a strong indication that the court recognizes the legal and factual strength of EES’s position. Judges in multiple jurisdictions have now described Shurka’s filings as “baseless” and “futile,” repeatedly returning the cases to the very courts where EES first initiated them – and where EES continues to win.

    Truth Over Deception

    The latest decision follows months of extensive filings exposing what EES alleges was a coordinated campaign of misinformation and brand confusion.

    Court records show that Shurka, once briefly involved in limited marketing activities with EES, launched a competing venture falsely implying that his product was identical to or derived from the original EESystem technology.

    EES’s lawsuits in Nevada and New York detail how Shurka and TLS misrepresented their affiliation, misused EES’s intellectual property, and exploited public imagery and research to promote their imitation product. These filings cite violations under the Lanham Act (15 U.S.C. § 1125) and the Nevada Deceptive Trade Practices Act, among others.

    “This is not about competition; it’s about protecting decades of honest work and innovation,” said Hon. Dr. Sandra Rose Michael, DNM, DCSJ, founder and inventor of the EESystem.
    “I began developing this technology in 1978 – long before these individuals appeared. We will continue to safeguard our legacy of integrity and ensure that truth, not falsehood, guides our community.“

    The court’s decision authorizes EESystem to maintain course and proceed with its full motion to dismiss – a clear reaffirmation that authenticity and integrity prevail.

    “Every decision in our favor strengthens our evidence and unites our global centers even further,” added Mela Bertolacini, daughter of Sandra Rose Michael and EESystem spokesperson.

    A Legacy of Authentic Innovation

    For nearly five decades, Hon. Dr. Sandra Rose Michael, DNM, DCSJ, has guided the development of the Energy Enhancement System (EESystem) – a technology exploring how scalar-field and photonic energy environments interact with the human system.

    Energy Enhancement System, with hundreds of public centers across the globe, is recognized for its distinctive integration of research, engineering precision, and educational outreach.

    From its Nevada headquarters, Energy Enhancement System, LLC advances research and design in emerging energy sciences, fostering environments that encourage relaxation, coherence, and scientific curiosity. Since 1978, Dr. Michael’s work has emphasized innovation with integrity and the pursuit of deeper understanding at the intersection of science and consciousness.

    About Energy Enhancement System (EESystem)

    Founded by Hon. Dr. Sandra Rose Michael, DNM, DCSJ, Energy Enhancement System, LLC is a Nevada-based research and technology company dedicated to the responsible exploration of scalar-field and photonic energy phenomena. The company’s mission is to promote transparency, education, and the ongoing study of coherence-based environments in collaboration with scientists, practitioners, and community centers worldwide.

    For transparency and public verification, case details are available through official court dockets: Energy Enhancement System, LLC v. Shurka et al., Case No. A-25-910216-B (Clark County District Court, Nevada); 2:2025cv00633 (U.S. District Court, District of Nevada); 1:25-cv-00218 / 1:25-cv-20981 (U.S. District Court, Southern District of Florida); and 2:25-cv-01234 (U.S. District Court, Eastern District of New York).

    Media Contact
    Energy Enhancement System, LLC
    support@eesystem.com
    www.eesystem.com

    Energy Enhancement System – Where Truth, Science, and Integrity Continue to Prevail.

    SOURCE: Energy Enhancement System

    View the original press release on ACCESS Newswire

  • enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update

    enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update

    – Cash and investments are sufficient to fund current operations through Q2 2027, not including VenoValve commercialization and the enVVe IDE study

    – Cash burn of $4.2 million in Q3 remains in line with projected quarterly range

    – Ongoing engagement with FDA for supervisory appeal of the VenoValve PMA decision with feedback expected by the end of 2025

    IRVINE, CA / ACCESS Newswire / October 31, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) (“enVVeno Medical” or the “Company”), a company setting new standards of care for the treatment of deep venous disease, today reported financial results for the third quarter 2025.

    Summary of Financial Results for the Third Quarter 2025

    The Company ended the quarter with $31.0 million in cash and investments. With the VenoValve commercializations costs and enVVe IDE expenses currently on hold pending resolution with the FDA, this capital has the potential to fund the Company through the second quarter of 2027. The Company expects its cash burn rate to increase from current levels in the event the Company proceeds to commercialization of the VenoValve and the IDE study with enVVe.

    Cash burn for the quarter was $4.2 million, consistent with the Company’s projected cash burn rate of approximately $4-5 million per quarter.

    The Company reported net losses of $4.5 million and $5.6 million for the three months ended September 30, 2025 and 2024, respectively, representing a decrease in net loss of $1.1 million, or 20%, due to a decrease in operating expenses of $1.3 million, partially offset by a decrease in other income of $0.2 million.

    “We are well capitalized and should have sufficient capital to cover the period of our ongoing discussions with the FDA seeking a potential commercial path forward for the VenoValve and clarity for the enVVe IDE study,” commented Robert Berman, CEO of enVVeno Medical. “Our recent in-person appeal meeting with the FDA provided a focused setting to address the concerns outlined in the not-approvable letter, including safety concerns raised by the FDA, proposed mitigations, the VenoValve’s effectiveness, and also provided the opportunity for the Agency to hear directly from one of our primary investigators and a patient from the VenoValve study. We look forward to our continued interactions with the FDA and remain committed to the 2.5 million patients suffering from severe deep chronic venous insufficiency.”

    Clinical Program Progress

    VenoValve®: Novel, First-In-Class Surgical Replacement Venous Valve

    • Filed a request for supervisory appeal of the not-approvable letter from the Center for Devices and Radiological Health (CDRH) received on August 19, 2025, in response to its Premarket Approval (PMA) application for the VenoValve®, a surgical replacement venous valve for treating severe deep chronic venous insufficiency (CVI)

    • Completed the in-person appeal meeting with the FDA. Participants included a patient as well as one of the primary investigators from VenoValve U.S. pivotal study

    • Decision from this stage of the appeal expected before year end 2025

    enVVe®: Novel, First-In-Class Non-Surgical Transcatheter-Based Replacement Venous Valve

    • Successfully completed final wave for the shorter-term subjects in 6-month pre-clinical GLP study

    • Successfully completed other testing necessary for IDE filing and awaiting the final consolidated study report

    • Targeting IDE filing for enVVe pivotal trial following clarity gained from VenoValve appeal process

    About enVVeno Medical Corporation

    enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company’s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs.

    Cautionary Note on Forward-Looking Statements

    This press release and any statements of stockholders, directors, employees, representatives and partners of enVVeno Medical Corporation (the “Company”) related thereto contain, or may contain, among other things, certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements identified by words such as “projects,” “may,” “will,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential” or similar expressions. These statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties, including those detailed in the Company’s filings with the Securities and Exchange Commission. Actual results and timing (may differ significantly from those set forth or implied in the forward-looking statements. Forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company’s control). The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future presentations or otherwise, except as required by applicable law.

    ###

    INVESTOR CONTACT:

    Jenene Thomas, JTC Team, LLC
    NVNO@jtcir.com
    (908) 824-0775

    MEDIA CONTACT:
    Glenn Silver, FINN Partners
    Glenn.Silver@finnpartners.com
    (973) 818-8198

    SOURCE: enVVeno Medical Corporation

    View the original press release on ACCESS Newswire

  • Tecogen Schedules Earnings Release Date and Conference Call for Q3 2025 Results

    Tecogen Schedules Earnings Release Date and Conference Call for Q3 2025 Results

    BILLERICA, MA / ACCESS Newswire / October 31, 2025 / Tecogen Inc. (NYSE American:TGEN) will release Q3 2025 financial results on Tuesday November 12th after close of market. The earnings press release and supplemental earnings presentation will be available on the Company’s website at www.Tecogen.com in the “Investor Relations” section under “Financial Results.” Members of Tecogen’s senior management will hold a conference call and webcast on Thursday November 13th at 9:30 AM Eastern Time to discuss the Company’s financial performance for Q3 2025.

    The conference call will be available live via telephone and webcast. To listen to the audio portion, dial 877-407-7186 within the US and Canada or 201-689-8052 from other international locations. Participants should ask to join the Tecogen earnings call. Please begin dialing at least 10 minutes before the scheduled starting time. Alternately, to register for and listen to the webcast, go to Webcast.

    The earnings conference call will be recorded and available for playback one hour after the end of the call. To listen to the playback dial (877) 660-6853 within the US and Canada or (201) 612-7415 from other international locations. Use Access ID #: 13752231. The webcast will be archived for 14 days following the call.

    About Tecogen

    Tecogen designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customer’s carbon footprint. In business for over 35 years, Tecogen has shipped more than 3,200 units, supported by an established network of engineering, sales, and service personnel in key markets in North America. For more information, please visit www.tecogen.com or contact us for a free Site Assessment.

    Forward Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 and other federal securities laws that involve a number of risks and uncertainties. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “project,” “target,” “potential,” “will,” “should,” “seek,” “could,” “likely,” “may,” “pro forma,” “anticipate,” “continue,” or other variations thereof (including their use in the negative), or by discussions of strategies, plans or intentions. All statements, other than statements of historical fact included in this press release regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management are forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements.

    In addition to those factors described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and in our Form 8-K, under “Risk Factors,” among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth.

    Tecogen Media & Investor Relations Contact Information:

    Abinand Rangesh, CEO
    P: 781-466-6487
    E: Abinand.Rangesh@tecogen.com

    SOURCE: Tecogen, Inc.

    View the original press release on ACCESS Newswire

  • Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma

    Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma

    CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company’s investigational mRNA-based T-cell engager (TCE) for participants with relapsed or refractory multiple myeloma (RRMM). The first dose was administered at SCRI Oncology Partners in Nashville, Tennessee, in collaboration with Sarah Cannon Research Institute (SCRI).

    mRNA-2808 is an investigational, multiplexed therapy that encodes three TCEs that target three validated myeloma-associated antigens. This novel strategy aims to address tumor heterogeneity and overcome known mechanisms of target-mediated resistance.

    “This is an important milestone as it is Moderna’s first T-cell engager therapy to be dosed in a patient. Given the vast unmet needs in multiple myeloma, I believe we can help improve the lives of these patients with innovative therapies,” said Dr. Kyle Holen, Head of Development, Oncology at Moderna. “Our mRNA platform uniquely allows for the multiplexing of several T-cell engager targets, designed to attack the disease from multiple angles to overcome, reduce and prevent escape mechanisms. We are proud to launch our first, of what we hope are many, T-cell engager therapies as we continue on our mission to transform cancer care for patients in need.”

    “Multiple myeloma is a complex cancer with many patients inevitably developing a resistance to available therapies, and attaining sustained disease control remains a challenge,” said Dr. Hans Lee, Director of Myeloma Research at SCRI and Hematologist and Medical Oncologist at SCRI Oncology Partners. “At SCRI, our mission is to bring tomorrow’s breakthroughs to the patients who need them today. mRNA-based therapies could change the way we think about treating cancers like multiple myeloma, and we are proud to provide our patients with access to this clinical trial.”

    This study (NCT07116616) is a dose escalation study evaluating the safety and tolerability of mRNA-2808 in RRMM patients aged 18 years and older. To learn more about eligibility, please click here.

    About Moderna

    Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including pioneering work on COVID-19 vaccines.

    Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the potential for Moderna’s mRNA platform to help transform cancer care; and the potential of mRNA-2808 to address tumor heterogeneity and overcome known mechanisms of target-mediated resistance. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

    Moderna Contacts

    Media:
    Chris Ridley
    Head of Global Media Relations
    +1 617-800-3651
    Chris.Ridley@modernatx.com

    Investors:
    Lavina Talukdar
    Senior Vice President & Head of Investor Relations
    +1 617-209-5834
    Lavina.Talukdar@modernatx.com

    SOURCE: Moderna, Inc.

    View the original press release on ACCESS Newswire

  • Egypt to Open Grand Egyptian Museum With Strong National Partnerships

    Egypt to Open Grand Egyptian Museum With Strong National Partnerships

    • Mohamed El-Etreby: The National Bank of Egypt is proud of its strategic role in supporting Egyptian heritage.

    • Hesham Talaat: GEM is a milestone that is reshaping Egypt’s cultural landscape and presenting the nation to the world in a truly magnificent light.

    • Sir Mohamed Mansour: The museum’s opening is a significant moment for Egyptian tourism.

    • Ahmed Ezz: We are proud that our rebars have been used in the construction of this iconic landmark.

    • Hassan Allam: Proud to operate the GEM under a public-private Partnership Agreement

    • Khaled Abbas: GEM is a declaration of Egypt’s enduring greatness, a fusion of legacy and progress that will inspire generations to come.

    CAIRO, EG / ACCESS Newswire / October 31, 2025 / Egypt is set to open the Grand Egyptian Museum (GEM) in November, an event billed as one of the most significant cultural milestones of the decade.

    The Grand Egyptian Museum Opening
    The Grand Egyptian Museum Opening

    Several leading Egyptian companies are official partners in the project, highlighting the role of national institutions in supporting culture and tourism.

    Hesham Talaat Moustafa, CEO of Talaat Moustafa Group, said “We are proud to be partners in the opening of the GEM, a milestone that is reshaping Egypt’s cultural landscape and presenting the nation to the world in a truly magnificent light.

    Sir Mohamed Mansour, Chairman of Mansour Group, said the opening “marks a transformative milestone for Egypt’s tourism industry”, adding that the museum will showcase Egypt in its best light to the world.

    Ahmed Ezz, Chairman of Ezz Steel, noted: “We are proud that our rebars have been used in the construction of this iconic landmark. We are equally honoured to partner with GEM, a monument that bridges Egypt’s 7,000 years of heritage with its bright future.”

    Hassan Allam, CEO of Hassan Allam Holding, highlighted, “For nearly 90 years, Hassan Allam Holding has been driving Egypt’s progress through transformative infrastructure and landmark projects. With expertise spanning engineering, construction, investment, and development across 10 countries, Egypt remains at the heart of our regional growth. We take pride in operating the Grand Egyptian Museum – a new chapter in Egypt’s journey towards building for the future.”

    Mohamed El-Etreby, Chairman of the National Bank of Egypt, stressed the bank’s pride in its strategic partnership: “The National Bank of Egypt, the country’s oldest financial institution and a cornerstone of its economy, is proud to be part of this project.”

    Khaled Abbas, Chairman and Managing Director of the Administrative Capital for Urban Development, stated that the GEM stands as a monumental gateway where the spirit of Ancient Egypt meets the bold future of our New Capital. This opening is not just a cultural milestone; it is a declaration of Egypt’s enduring greatness, a fusion of legacy and progress that will inspire generations to come.

    Contact Information

    Eman Salem
    press@30n.org

    .

    SOURCE: 30N

    View the original press release on ACCESS Newswire

  • Poain BlockEnergy Inc. Expands Global Operations with AI-Based DeFi and Cross-Chain Staking Solutions

    Poain BlockEnergy Inc. Expands Global Operations with AI-Based DeFi and Cross-Chain Staking Solutions

    Denver, CO November 02, 2025 –(PR.com)– As the digital economy matures, the focus in blockchain technology is shifting from speculation toward sustainable, data-driven systems. Poain BlockEnergy Inc. continues its international expansion by integrating artificial intelligence (AI) with decentralized finance (DeFi) to enhance cross-chain staking infrastructure.

    International Growth and Market Expansion

    Poain BlockEnergy, which is extending operations across North America, Europe, and Asia in 2025, maintains regional hubs supporting blockchain development, financial analytics, and AI research. Its multilingual platform and compliance-oriented framework enable the company to serve participants across multiple jurisdictions.

    The company’s objective is to provide a unified digital environment where users can manage staking activities across different blockchains efficiently. AI-driven systems help improve operational stability and diversification across networks.

    Intelligent Processing in DeFi

    At the core of Poain BlockEnergy’s model is an AI-based DeFi engine designed to optimize staking and liquidity allocation across blockchain networks. Unlike traditional manual approaches, the system reviews factors such as validator performance and network throughput to manage staking pools dynamically.

    This automated process aims to provide consistent network participation while improving efficiency. The AI framework also supports security monitoring by identifying potential vulnerabilities or irregular activity, contributing to a safer and more transparent environment for users.

    Institutional Engagement

    Poain BlockEnergy’s ecosystem also serves institutional clients. With greater institutional involvement in digital assets, the company provides staking solutions adapted to the needs of funds, family offices, and enterprise participants that require regulatory and compliance alignment.

    Poain’s infrastructure includes KYC/AML verification and cold-storage safeguards. A forthcoming institutional dashboard will allow clients to track staking performance and generate internal reports within the platform.

    Sustainable Participation Models

    Poain’s flexible staking options allow participants to choose varying engagement durations based on their preferences. The company’s structure is designed to align with market conditions and evolving risk management strategies. All participation terms and results depend on blockchain network conditions and are not guaranteed.

    Conclusion

    Poain BlockEnergy Inc. is advancing AI-assisted decentralized finance by combining automation, compliance, and cross-chain technology. As adoption of blockchain infrastructure continues globally, the company aims to contribute to the development of more efficient and transparent digital finance systems.

    Media Contact

    Company: Poain BlockEnergy Inc.
    Email: info@poain.com
    Website: https://poain.com

    Contact Information:
    Poain BlockEnergy Inc
    George James
    +1 252 515-0119
    Contact via Email
    https://poain.com/

    Read the full story here: https://www.pr.com/press-release/952704

    Press Release Distributed by PR.com

  • adops.com Expands Into Latin America

    adops.com Expands Into Latin America

    Panama, Panama November 03, 2025 –(PR.com)– Today, adops.com announced it is part of the Google Certified Publishing Partner (GCPP) program in Spanish-speaking Latin America (SPLA). This expansion brings the benefits of the GCPP to publishers across nine countries in the region, providing access to Google Ad Manager, along with the knowledge and capabilities needed to help publishers grow.

    Now, with adops.com, more SPLA publishers can use Ad Manager and the guidance that comes with it, including access to the education and training they need on best practices for monetization.

    Craig Leshen, CEO of adops.com, said the announcement is a direct reflection of the company’s long-standing commitment to helping publishers maximize the value of their advertising technology.

    “Nuestra nueva participación en el programa Google Certified Publishing Partner para Hispanoamérica es una extensión natural del trabajo que hemos realizado durante décadas,” expresó Leshen. “Hemos ayudado a editores en los Estados Unidos y Canadá a sacar el máximo provecho de Google Ad Manager 360, y ahora nos entusiasma brindar el mismo nivel de experiencia y soporte a los editores de toda esta región.”

    Publishers in SPLA will now gain access to GAM360 functionality that was previously unavailable to them. For many, this means they can upgrade to a more advanced platform that provides flexibility and tools required to maximize revenue. adops.com’s role goes beyond reselling the platform, however. adops.com will provide technical support, implementation services, and ongoing strategic guidance that help publishers deploy and manage Ad Manager effectively.

    Leshen also emphasized that the opportunity is about more than technology.

    “Hispanoamérica representa una oportunidad dinámica y de expansión para los editores,” comentó Leshen. “A través del programa Google Certified Publisher, podemos ofrecer toda la experiencia de nuestro equipo a la región, desde los conocimientos avanzados de la plataforma hasta la asistencia práctica para que los editores hispanoamericanos puedan aprovechar las nuevas oportunidades.”

    With their expansion into Spanish-speaking Latin America through this partnership, adops.com is reinforcing its mission to put publishers first, so they can grow revenue, strengthen operations, and compete more effectively in every market they serve.

    About adops.com
    adops.com is the execution partner that connects publisher goals to platform performance. With more than 20 years of hands-on experience, we operate inside the ad stack: solving problems, running campaigns, optimizing workflows, and helping both sides deliver under real-world conditions. We help publishers unlock revenue and help ad technology solutions partners get adopted where it counts. Embedded in your business. Designed to deliver results. That’s how advertising operations should be done.

    www.adops.com

    Contact Information:
    adops.com
    Marketing Department
    212-226-6788
    Contact via Email
    www.adops.com

    Read the full story here: https://www.pr.com/press-release/952728

    Press Release Distributed by PR.com

  • Ameripath USA Announces Strategic Partnership with Recovery Resolutions to Expand Access to Addiction Recovery Homes

    Ameripath USA Announces Strategic Partnership with Recovery Resolutions to Expand Access to Addiction Recovery Homes

    Drexel Hill, PA November 02, 2025 –(PR.com)– Ameripath USA, a national leader in seller-financed real estate investments and innovative housing solutions for underserved communities, is proud to announce its partnership with Recovery Resolutions LLC, a proven provider of Addiction Recovery Homes and co-living management services nationwide.

    Founded by Joshua Dirscherl, Recovery Resolutions brings over a decade of experience establishing and overseeing more than one hundred successful addiction recovery and co-living homes across the country. The company specializes in identifying prime properties, renovating them into supportive recovery environments, and managing daily operations to create safe, structured, and empowering communities that foster lasting healing and accountability.

    The Recovery Resolutions model has demonstrated a 95% success rate among residents who remain in the program, with a “stick rate” — the percentage of individuals who successfully stay through the recovery program — that is twice that of traditional sober living homes. This success is a direct result of the hands-on leadership and innovative systems developed by Founder Joshua Dirscherl, who continues to drive the organization’s mission of building sustainable, results-based recovery housing.

    Through this partnership, Ameripath USA and Recovery Resolutions will combine their complementary strengths — Ameripath USA’s expertise in property acquisition and development and Recovery Resolutions’ operational excellence in addiction recovery home management — to expand access to high-quality, affordable Addiction Recovery Homes across the United States.

    “Our mission has always been to provide housing solutions for those in need,” said Michael Kearse, CEO of Ameripath USA. “Partnering with Recovery Resolutions allows us to extend that mission into an area where stable, supportive housing is often the difference between relapse and recovery. Together, we’re creating safe, structured homes where individuals can truly rebuild their lives.”

    “At Recovery Resolutions, we believe that recovery starts with the right environment,” said Joshua Dirscherl, Founder and CEO of Recovery Resolutions LLC. “Our model is built on structure, community, and accountability — and our results show it works. Partnering with Ameripath USA allows us to expand this proven approach and help more people experience real, lasting recovery.”

    This collaboration represents a shared commitment to addressing the urgent need for quality addiction recovery housing across the nation. Together, Ameripath USA and Recovery Resolutions will deliver scalable, sustainable housing that provides dignity, structure, and opportunity for those on the path to healing.

    About Ameripath USA
    Ameripath USA is dedicated to expanding homeownership and housing opportunities for individuals and families often overlooked by traditional banking systems. Through innovative seller-financing models and partnerships, Ameripath USA creates sustainable pathways to housing stability and ownership.

    About Recovery Resolutions LLC
    Recovery Resolutions offers consulting, construction, and management services for Addiction Recovery Homes and co-living environments nationwide. With a track record of over 100 homes launched and maintained at exceptional success rates, Recovery Resolutions is setting a new standard for what recovery housing can be — structured, supportive, and results-driven.

    Contact Information:
    Ameripath USA
    Ryan Madigan
    877-905-4862
    Contact via Email
    www.ameripathusa.com

    Read the full story here: https://www.pr.com/press-release/952561

    Press Release Distributed by PR.com

  • Tom Wood Collision Offers Technology-Driven Repairs with Customer Care Focus

    Tom Wood Collision Offers Technology-Driven Repairs with Customer Care Focus

    Services Offered by Top Auto Body Shops: A Complete Guide for Indianapolis Drivers

    Indianapolis, United States – November 3, 2025 / Tom Wood Collision /

    Indianapolis, IN – Professional auto body shops today deliver far more than basic repairs. With advanced technology, manufacturer certifications, and customer-first processes, these facilities provide solutions that restore both vehicle safety and appearance. Tom Wood Collision Center, serving Indianapolis since 2012, highlights the wide range of services that set a top auto body shop apart from general repair facilities.

    Evolving Role of Auto Body Shops

    Top auto body shops provide a complete range of repair services that restore both vehicle safety and appearance, combining collision repair, cosmetic restoration, paint refinishing, and glass replacement under one roof. These shops operate with manufacturer standards, diagnostic systems, and repair procedures that maintain structural integrity, factory warranties, and resale value.

     

    Tom Wood Collision has grown into one of Indianapolis’s most trusted providers by maintaining more than 20 OEM certifications and investing in advanced diagnostic and repair technology.

    Key Services Offered by Professional Auto Body Shops

    Collision and Structural Repair

    Structural analysis, frame straightening, and safety system calibration form the core of professional collision repair. These services address hidden damage as well as visible body issues, restoring vehicles to factory specifications.

    Auto Body and Cosmetic Services

    Cosmetic repairs handle dents, scratches, and paint imperfections caused by daily use. Services such as bumper scuff removal and chip repair restore the original look while helping preserve long-term vehicle value.

    Paintless Dent Repair

    Paintless dent repair (PDR) is an efficient solution for hail damage and minor dings. By working behind panels without affecting the original finish, PDR preserves factory paint and reduces repair times.

    Paint and Refinishing Services

    Professional refinishing uses multi-stage applications and color-matching technology. Contamination-free spray booths maintain consistent results while protecting finish durability, whether for small touch-ups or complete repainting.

    Auto Glass and Windshield Services

    Windshield replacement and repair services restore visibility and safety. OEM-quality glass installation supports proper airbag deployment and roof strength, making professional service essential.

    Certified Standards and Training Requirements

    Certification defines the difference between a basic repair shop and a professional facility. Tom Wood Collision maintains certifications from manufacturers such as Porsche, Jaguar, Land Rover, Volvo, Lexus, Honda, Toyota, Ford, and General Motors.

     

    These certifications require technician training, specialized tools, and ongoing education. Certified facilities gain access to repair procedures and parts that non-certified shops cannot provide, allowing repairs to meet exact factory requirements.

    Integrated Services That Simplify the Repair Process

    Modern auto body shops do more than restore vehicles. They simplify the repair experience for drivers. At Tom Wood Collision, repair workflows are designed to minimize downtime and deliver consistent results.

     

    • Streamlined service coordination reduces delays by combining structural, cosmetic, and paint repairs under one roof.

    • Parts management systems track availability and support accurate repair timelines, even for specialty components.

    • Digital documentation provides a record of each repair stage, giving customers added confidence in the process.

    • Dedicated service representatives keep drivers updated with progress reports and clear communication.

     

    By focusing on efficiency and transparency, Tom Wood Collision Center helps Indianapolis drivers navigate the repair process with less stress and faster results.

    Supporting Services and Customer Care

    Professional auto body shops provide services that reduce stress throughout the repair process. Insurance claim management includes adjuster coordination, repair authorization, and direct billing. Customers benefit from fewer paperwork delays and more accurate claim processing.

     

    Customer service protocols ensure progress updates, clear communication, and prompt responses to questions. Tom Wood Collision Center assigns service representatives as points of contact, helping customers feel supported throughout repair timelines.

    Tom Wood Collision: A Trusted Auto Body Shop in Indianapolis

    From structural repairs to paint refinishing and insurance claim support, certified auto body shops provide solutions that protect safety and appearance while delivering a better customer experience. Tom Wood Collision Center combines technology, certifications, and care to serve Indianapolis drivers with confidence.

     

    Drivers searching for an auto body shop in Indianapolis can rely on Tom Wood Collision Center for collision repair, cosmetic services, paint refinishing, and glass replacement backed by more than a decade of expertise. Contact Tom Wood Collision at (317) 848-6707 to request your repair estimate and discover why drivers trust this certified auto body shop near you for professional collision and cosmetic services.

    Contact Information:

    Tom Wood Collision

    9727 Bauer Dr E
    Indianapolis, IN 46280
    United States

    Joshua Piccione
    (317) 848-6707
    https://www.tomwoodcollision.com/

    Facebook LinkedIn

    Original Source: https://www.tomwoodcollision.com/blog/2025/october/8/services-offered-by-top-auto-body-shops-a-complete-guide-for-indianapolis-drivers.htm

  • USA Cabinet Store Unveils 2026 Kitchen and Bath Design Trends Aligned with National Industry Forecasts

    USA Cabinet Store Unveils 2026 Kitchen and Bath Design Trends Aligned with National Industry Forecasts

    TAMPA, FL – October 31, 2025 – PRESSADVANTAGE –

    USA Cabinet Store Tampa announces its alignment with the National Kitchen & Bath Association’s 2026 design forecasts, featuring curated collections that reflect emerging preferences for natural materials, minimalist aesthetics, and wellness-focused spaces in residential remodeling projects.

    The Tampa Showroom has positioned its product offerings to match industry predictions that show wood grain surpassing painted cabinets as the preferred choice for 51 percent of design professionals surveyed. The company’s Fabuwood Illume frameless cabinetry line and Jeffrey Alexander vanity collections directly correspond with documented kitchen remodel trends 2026 that emphasize clean silhouettes, warm wood tones, and sustainable materials.

    kitchen and bath remodel trends 2026 tampa

    According to the NKBA’s September 2025 report, 76 percent of industry respondents expect kitchen footprints to expand over the next three years, with islands evolving into collaborative zones featuring beverage stations and pet feeding areas. These findings align with USA Cabinet Store’s comprehensive kitchen and bath remodel services that transform spaces into personalized, multi-purpose hubs.

    “The current market dynamics have created unprecedented demand for home renovations as homeowners invest in their current properties rather than facing challenging real estate conditions,” said Emin Halac, CEO of USA Cabinet Store. “Our curated collections featuring frameless cabinetry and floating vanities directly address the minimalist design movement while incorporating the warm wood tones and natural materials that define contemporary residential preferences.”

    The company’s product selection reflects specific bathroom remodel trends 2026, including the dominance of floating vanities for space optimization, the shift from chrome to matte black and brushed gold hardware finishes, and the integration of spa-inspired elements such as tower storage and mood lighting. These design directions support the growing emphasis on bathrooms as personal retreats that prioritize emotional resonance and sensory comfort.

    USA Cabinet Store’s Fabuwood Illume series exemplifies the frameless construction trend with its Threespine engineering and full-access design that maximizes storage capacity while maintaining clean, minimalist silhouettes. The collection’s deep, natural finish options align with industry data showing white oak as the leading wood choice among design professionals, while integrated Blum premium hardware ensures functionality matches aesthetic appeal.

    The Jeffrey Alexander vanity program available through USA Cabinet Store offers over 4,000 design combinations, featuring hardwood construction with moisture-resistant sealing particularly suited for humid climates. These vanities incorporate soft-close hinges and multiple hardware finishes that correspond with documented preferences for warm metallics and statement hardware pieces.

    Industry analysis reveals that kitchen remodeling in Tampa generates a 76 percent return on investment compared to the national average of 68 percent, while bathroom renovations achieve an 84 percent return. These statistics underscore the value of professional remodeling services that incorporate trending design elements and quality materials.

    USA Cabinet Store operates 13 showrooms across Virginia, Maryland, North Carolina, Texas, New Jersey, Florida, and Tennessee. The company provides comprehensive kitchen and bath remodel services from initial consultation through final installation, specializing in custom cabinet installations, premium materials, and storage solutions that combine functionality with design aesthetics. Since 2011, the company has completed projects for more than 900 customers, offering white glove delivery service and detailed process guidance throughout each renovation.

    ###

    For more information about USA Cabinet Store , contact the company here:

    USA Cabinet Store Tampa
    Emin Halac
    813-252-6633
    tampa@usacabinetstore.com
    11913 N Dale Mabry Hwy, Tampa, FL 33618, United States